نتایج جستجو برای: soluble aβ1 42

تعداد نتایج: 198217  

2012
ERIK PORTELIUS JUAN FORTEA JOSE LUIS MOLINUEVO MIKAEL K. GUSTAVSSON ULF ANDREASSON RAQUEL SANCHEZ-VALLE

There are several familial forms of Alzheimer's disease (AD) most of which are caused by mutations in the genes that encode the presenilin enzymes involved in the production of amyloid-β (Aβ) from the amyloid precursor protein (APP). In AD, Aβ forms fibrils that are deposited in the brain as plaques. Much of the fibrillar Aβ found in the plaques c...

2015
Ross W. Paterson Jamie Toombs Miles D. Chapman Jennifer M. Nicholas Amanda J. Heslegrave Catherine F. Slattery Alexander J.M. Foulkes Camilla N. Clark Christopher A.S. Lane Philip S.J. Weston Michael P. Lunn Nick C. Fox Henrik Zetterberg Jonathan M. Schott

INTRODUCTION Cerebrospinal fluid (CSF) neurodegenerative markers are measured clinically to support a diagnosis of Alzheimer's disease. Several preanalytical factors may alter the CSF concentrations of amyloid β 1-42 (Aβ1-42) in particular with the potential to influence diagnosis. We aimed to determine whether routine handling of samples alters measured biomarker concentration compared with th...

2016
Lu Yang Yun Li Arup Bhattacharya Yuesheng Zhang

Coagulation factors are essential for hemostasis. Here, we show that these factors also team up to degrade plasma proteins that are unrelated to hemostasis. Prolidase, SRC and amyloid β1-42 (Aβ1-42) are used as probes. Each probe, upon entering the blood circulation, binds and activates factor XII (FXII), triggering the intrinsic and common coagulation cascades, which in turn activate factor VI...

2017
Marie-Elyse Lafaille-Magnan Judes Poirier Pierre Etienne Jennifer Tremblay-Mercier Joanne Frenette Pedro Rosa-Neto John C.S. Breitner

OBJECTIVE To assess odor identification (OI) as an indicator of presymptomatic Alzheimer disease (AD) pathogenesis in cognitively normal aging individuals at increased risk of AD dementia. METHODS In 274 members of the PREVENT-AD cohort of healthy aging persons with a parental or multiple-sibling history of AD dementia, we assessed the cross-sectional association of OI with potential indicato...

2014
Hye Youn Sung Eun Nam Choi Dahyun Lyu Inhee Mook-Jung Jung-Hyuck Ahn

Swedish double mutation (KM670/671NL) of amyloid precursor protein (APP) is reported to increase toxic amyloid β (Aβ) production via aberrant cleavage at the β-secretase site and thereby cause early-onset Alzheimer's disease (AD). However, the underlying molecular mechanisms leading to AD pathogenesis remains largely unknown. Previously, our transcriptome sequence analyses revealed global expre...

2017
Márcia Radanovic Florindo Stella Lis Gomes Silva Leda L. Talib Orestes V. Forlenza

Cognitive impairment includes mild cognitive decline and dementia, such as Alzheimer's disease (AD) and cerebrovascular-related pathologies. Objective To investigate the profile of AD-related CSF biomarkers in a sample of cognitively impaired and unimpaired older adults with concomitant subcortical cerebrovascular burden. Methods Seventy-eight older adults attending an outpatient psychogeri...

Journal: :Neurobiology of aging 2012
Stephanie Vos Ineke van Rossum Leah Burns Dirk Knol Philip Scheltens Hilkka Soininen Lars-Olof Wahlund Harald Hampel Magda Tsolaki Lennart Minthon Ron Handels Gilbert L'Italien Wiesje van der Flier Pauline Aalten Charlotte Teunissen Frederik Barkhof Kaj Blennow Robin Wolz Daniel Rueckert Frans Verhey Pieter Jelle Visser

Our aim was to identify the best diagnostic test sequence for predicting Alzheimer's disease (AD)-type dementia in subjects with mild cognitive impairment (MCI) using cerebrospinal fluid (CSF) and magnetic resonance imaging (MRI) biomarkers. We selected 153 subjects with mild cognitive impairment from a multicenter memory clinic-based cohort. We tested the CSF beta amyloid (Aβ)1-42/tau ratio us...

Journal: :Journal of Alzheimer's disease : JAD 2010
Francisco J Gil-Bea Maite Solas Alina Solomon Carmen Mugueta Bengt Winblad Miia Kivipelto Maria J Ramirez Angel Cedazo-Mínguez

Previous studies have failed to reach consensus on insulin levels in cerebrospinal fluid of Alzheimer's disease (AD) patients and on its relation to pathological features. We performed a new analysis in patients at different stages of AD, and investigated the relationship of insulin levels with biochemical disease markers and with cognitive score. We included 99 patients from our Memory Clinic ...

2012
Jing Zheng Cong Liu Michael R. Sawaya Balraju Vadla Shafiullah Khan R. Jeremy Woods David Eisenberg Warren J. Goux James S. Nowick

The captions for Figure 2C,D have several minor errors numbering of the residues of Aβ. The corrected captions should read: (C) NMR-based structural model of Aβ1−40 fibrils showing central residues K16−D22 and A30−V36. (D) NMR-based structural model of Aβ1−42 fibrils showing central residues L17−I41. These errors are peripheral to this paper and do not affect the results or conclusions in any way.

2015
Lucette A Cysique Timothy Hewitt Juliana Croitoru-Lamoury Kevin Taddei Ralph N Martins Constance SN Chew Nicholas NWS Davies Patricia Price Bruce J Brew

BACKGROUND Cerebrospinal fluid (CSF) biomarkers Aβ1-42, t-tau and p-tau have a characteristic pattern in Alzheimer's Disease (AD). Their roles in HIV-associated neurocognitive disorder (HAND) remains unclear. METHODS Adults with chronic treated HIV disease were recruited (n = 43, aged 56.7 ± 7.9; 32% aged 60+; median HIV duration 20 years, >95% plasma and CSF HIV RNA <50 cp/mL, on cART for a ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید